Review




Structured Review

Merck & Co dapt stock solution
Dapt Stock Solution, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/dapt/pm35477753-482-0-5
Average 90 stars, based on 1 article reviews
dapt stock solution - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Recombinant:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Transduction:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

CRISPR:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Gene Knockout:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Expressing:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Concentration Assay:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Immunofluorescence:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Western Blot:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Flow Cytometry:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Sequencing:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Red Blood Cell Lysis:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Cell Recovery:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Plasmid Preparation:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

SYBR Green Assay:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Reverse Transcription:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Software:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Microscopy:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Magnetic Beads:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Transmission Assay:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Acetylene Reduction Assay:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Control:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Activation Assay:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.

Staining:

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10μM DAPT and 5μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.
Article Snippet: Hirofumi Noguchi, Chika Miyagi-Shiohira, Takuya Sadahira, Masami Watanabe, and Issei Saitoh Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; and Department of Pediatric Dentistry, Asahi University School of Dentistry, Hozumi, Japan.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition.
Article Snippet: The following day (DIV42), cells were treated with 10 mM DAPT and 5 mM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: Synaptic neoteny of human cortical neurons requires species-specific balancing of SRGAP2-SYNGAP1 cross-inhibition
Article Snippet: The following day (DIV42), cells were treated with 10 μM DAPT and 5 μM Cytarabine (ARA-C) (Merck, Cat#C3350000) for 24 hours.

Article Title: HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models
Article Snippet: On the third day, medium was replaced by Neurobasal/B27 (Neurobasal medium, Thermo Fisher Scientific; 1X B27, Thermo Fisher Scientific; 1X Glutamax; 1X NEAA; 0.5X P/S) supplemented with 5 μM DAPT, 4 μM SU5402 (both from Merck Life Sciences) and 1 μg/ml doxycycline for 3 days.



Similar Products

95
MedChemExpress dapt solution
Dapt Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/DAPT/pm40341648-127-7-9
Average 95 stars, based on 1 article reviews
dapt solution - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
Millipore γ-secretase inhibitor dapt solution
γ Secretase Inhibitor Dapt Solution, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/dapt/pmc10869796-352-3-7
Average 90 stars, based on 1 article reviews
γ-secretase inhibitor dapt solution - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
Selleck Chemicals dmso working solution
Dmso Working Solution, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/DAPT/pm37056149-49-20-25
Average 96 stars, based on 1 article reviews
dmso working solution - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
FUJIFILM dapt solution
The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor <t>DAPT.</t> (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without <t>50µM</t> of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.
Dapt Solution, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/dapt/bio_rxiv__2023__07__19__549786-186-12-18
Average 90 stars, based on 1 article reviews
dapt solution - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
Selleck Chemicals dapt working solution
The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor <t>DAPT.</t> (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without <t>50µM</t> of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.
Dapt Working Solution, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/DAPT/pm37083721-51-1-12
Average 96 stars, based on 1 article reviews
dapt working solution - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Thermo Fisher v v mem non essential amino acids solution thermo fisher scientific catalogue no 11140050
The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor <t>DAPT.</t> (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without <t>50µM</t> of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.
V V Mem Non Essential Amino Acids Solution Thermo Fisher Scientific Catalogue No 11140050, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/DAPT/pm36655405-292-27-33
Average 95 stars, based on 1 article reviews
v v mem non essential amino acids solution thermo fisher scientific catalogue no 11140050 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
Merck & Co dapt stock solution
The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor <t>DAPT.</t> (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without <t>50µM</t> of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.
Dapt Stock Solution, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/dapt/pm35477753-482-0-5
Average 90 stars, based on 1 article reviews
dapt stock solution - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Cayman Chemical dapt solution
The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor <t>DAPT.</t> (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without <t>50µM</t> of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.
Dapt Solution, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapt+solution/dapt/pmc08355240-475-4-42
Average 90 stars, based on 1 article reviews
dapt solution - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor DAPT. (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without 50µM of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.

Journal: bioRxiv

Article Title: The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy

doi: 10.1101/2023.07.19.549786

Figure Lengend Snippet: The improvement of mitochondrial abnormalities in MFN2-deficient human iPS cells treated with gamma-secretase inhibitor DAPT. (A) Mitochondrial morphology visualized by MitoTracker in MFN2-deficient human iPS cells with or without 50µM of DAPT. (Right panels; magnified area outlined in right panels), Scale bars; 50 µm. (B) Relative transcription levels of HES1 and HEY1 in MFN2-deficient human iPS cells with or without DAPT. (C) MAM visualization in MFN2-deficient human iPS cells, with or without DAPT. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) The quantitative analyses of MAM numbers in MFN2-deficient human iPS cells with or without DAPT. (E) Total ATP production in MFN2-deficient human iPS cells treated with or without DAPT. All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests for comparisons. *P<0.05.

Article Snippet: TA muscle was removed 2 weeks after transplantation with several injections of DAPT solution (20µL of 50µM stock, WAKO) as shown in , fixed, and stained as above.

Techniques:

The regenerative capacity of Mfn2-deficient mouse muscle is reduced and that of Mfn2-deficient muscle stem cells when transplanted into Dystrophic muscle in vivo is improved by DAPT treatment of the muscle. (A) The flowchart to isolate muscle stem cells (MuSCs, SM-C/2.6+) and non-myogenic fibroblasts (FBs) derived from conditionally Mfn2 knockout mice after 4-OH tamoxifen (4-OHT) injection. (B) Immunostaining for Mfn2 (Green), Myogenin (Myog; Red), and DAPI (blue) on differentiated myotubes derived from wildtype or Mfn2-deficient mouse muscle stem cells sorted as SM-C/2.6 positive cells, co-cultured with non-myogenic fibroblasts (FBs). Scale bar; 50 µm. (C) Phase contrast images (left panels) and MAMs visualization (right panels) and quantitative analyses of MAM numbers (right) on cultured muscle stem cells. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) Western Blotting analyses of lysates from control and Mfn2-mutant cultured muscle stem cells. Nuclear lysates were analyzed with antibodies against NICD. Histone H3 was used as a loading control. (E) The flowchart for the transplantation into tibialis anterior (TA) muscles of DMD -/y mice (12 weeks old) with Mfn2-deficient muscle stem cells (1.0 x 10 4 cells) and the treatment with DAPT every 3∼4 days after the transplantation. (F) Transverse sectional images of TA muscles 14 days after the transplantation with the same number of muscle stem cells sorted as SM/C-2.6-positive cells derived from wildtype or conditional Mfn2 Knockout mice. Immunostaining for Dystrophin (Dmd, red as transplanted areas), laminin-a2 (Lama2, white to show the outline of myofibers), and DAPI (blue) on engrafted TA muscle after the transplantation. Scale bars; 50 µm. (G) The quantification of the total number of Dystrophin-positive (Dmd+) regenerated myofibers on the section transplanted with an equivalent number of normal or Mfn2-deficient MuSCs, with or without the treatment of the transplanted muscle with DAPT. (H) The average diameter of Dystrophin-positive (Dmd+) myofibers that are contributed by the transplanted MuSCs, as described in (G). All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests or one-way ANOVA and Tukey’s test for comparisons. *P<0.05.

Journal: bioRxiv

Article Title: The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy

doi: 10.1101/2023.07.19.549786

Figure Lengend Snippet: The regenerative capacity of Mfn2-deficient mouse muscle is reduced and that of Mfn2-deficient muscle stem cells when transplanted into Dystrophic muscle in vivo is improved by DAPT treatment of the muscle. (A) The flowchart to isolate muscle stem cells (MuSCs, SM-C/2.6+) and non-myogenic fibroblasts (FBs) derived from conditionally Mfn2 knockout mice after 4-OH tamoxifen (4-OHT) injection. (B) Immunostaining for Mfn2 (Green), Myogenin (Myog; Red), and DAPI (blue) on differentiated myotubes derived from wildtype or Mfn2-deficient mouse muscle stem cells sorted as SM-C/2.6 positive cells, co-cultured with non-myogenic fibroblasts (FBs). Scale bar; 50 µm. (C) Phase contrast images (left panels) and MAMs visualization (right panels) and quantitative analyses of MAM numbers (right) on cultured muscle stem cells. (Red; MAM (IP3R-VDAC1 PLA), blue; DAPI, Scale bars; 20 µm. (D) Western Blotting analyses of lysates from control and Mfn2-mutant cultured muscle stem cells. Nuclear lysates were analyzed with antibodies against NICD. Histone H3 was used as a loading control. (E) The flowchart for the transplantation into tibialis anterior (TA) muscles of DMD -/y mice (12 weeks old) with Mfn2-deficient muscle stem cells (1.0 x 10 4 cells) and the treatment with DAPT every 3∼4 days after the transplantation. (F) Transverse sectional images of TA muscles 14 days after the transplantation with the same number of muscle stem cells sorted as SM/C-2.6-positive cells derived from wildtype or conditional Mfn2 Knockout mice. Immunostaining for Dystrophin (Dmd, red as transplanted areas), laminin-a2 (Lama2, white to show the outline of myofibers), and DAPI (blue) on engrafted TA muscle after the transplantation. Scale bars; 50 µm. (G) The quantification of the total number of Dystrophin-positive (Dmd+) regenerated myofibers on the section transplanted with an equivalent number of normal or Mfn2-deficient MuSCs, with or without the treatment of the transplanted muscle with DAPT. (H) The average diameter of Dystrophin-positive (Dmd+) myofibers that are contributed by the transplanted MuSCs, as described in (G). All error bars indicate ±SEM (n=5). P -values are determined by non-parametric Wilcoxon tests or one-way ANOVA and Tukey’s test for comparisons. *P<0.05.

Article Snippet: TA muscle was removed 2 weeks after transplantation with several injections of DAPT solution (20µL of 50µM stock, WAKO) as shown in , fixed, and stained as above.

Techniques: In Vivo, Derivative Assay, Knock-Out, Injection, Immunostaining, Cell Culture, Western Blot, Mutagenesis, Transplantation Assay